Static

Novartis CEO Says US China Biotech Curbs Risk Drug Development

First reported by Bloomberg ·

The signal ●○○○ Brief pending · reported by Bloomberg, the single source so far
What happened

Novartis AG Chief Executive Officer Vas Narasimhan said proposed US restrictions on biotech investments in China could hamper the development of new medicines.

Source description shown. AI brief pending.

Health